JP2022509206A5 - - Google Patents
Info
- Publication number
- JP2022509206A5 JP2022509206A5 JP2021529827A JP2021529827A JP2022509206A5 JP 2022509206 A5 JP2022509206 A5 JP 2022509206A5 JP 2021529827 A JP2021529827 A JP 2021529827A JP 2021529827 A JP2021529827 A JP 2021529827A JP 2022509206 A5 JP2022509206 A5 JP 2022509206A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutical composition
- composition according
- pain
- heterocycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862772554P | 2018-11-28 | 2018-11-28 | |
| US62/772,554 | 2018-11-28 | ||
| PCT/US2019/063451 WO2020112905A1 (en) | 2018-11-28 | 2019-11-26 | Methods of treating disease with magl inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022509206A JP2022509206A (ja) | 2022-01-20 |
| JP2022509206A5 true JP2022509206A5 (https=) | 2022-11-28 |
Family
ID=70851863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021529827A Pending JP2022509206A (ja) | 2018-11-28 | 2019-11-26 | Ｍａｇｌ阻害剤による疾病の治療方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220031676A1 (https=) |
| EP (1) | EP3886844A4 (https=) |
| JP (1) | JP2022509206A (https=) |
| KR (1) | KR20210097734A (https=) |
| CN (1) | CN113347971A (https=) |
| AU (1) | AU2019389017B2 (https=) |
| BR (1) | BR112020015043A2 (https=) |
| CA (1) | CA3120577A1 (https=) |
| CL (1) | CL2021001363A1 (https=) |
| IL (1) | IL283508A (https=) |
| MA (1) | MA54313A (https=) |
| MX (1) | MX2021006312A (https=) |
| SG (1) | SG11202105320YA (https=) |
| WO (1) | WO2020112905A1 (https=) |
| ZA (1) | ZA202103975B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10927105B1 (en) | 2017-05-23 | 2021-02-23 | Lundbeck La Jolla Research Center, Inc. | Pyrazole MAGL inhibitors |
| EA201992409A1 (ru) | 2017-05-23 | 2020-03-23 | Лундбекк Ла-Хойя Рисерч Сентер, Инк. | Ингибиторы magl на основе пиразола |
| BR112023015210A2 (pt) | 2021-01-29 | 2023-11-07 | Cedilla Therapeutics Inc | Inibidores de cdk2 e métodos de uso dos mesmos |
| CA3225439A1 (en) | 2021-06-26 | 2022-12-29 | Cedilla Therapeutics, Inc. | Cdk2 inhibitors and methods of using the same |
| PE20241304A1 (es) | 2021-07-30 | 2024-06-24 | Confo Therapeutics N V | Compuestos para el tratamiento del dolor, en particular el dolor neuropatico, y/u otras enfermedades o trastornos que se asocian con at2r y/o senalizacion mediada por at2r |
| CN118139863A (zh) * | 2021-11-02 | 2024-06-04 | H.隆德贝克有限公司 | 单酰基甘油脂肪酶抑制剂的结晶形式 |
| CA3242372A1 (en) | 2021-12-29 | 2023-07-06 | Psy Therapeutics, Inc. | Inhibiting monoacylglycerol lipase (magl) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012524800A (ja) * | 2009-04-22 | 2012-10-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | モノアシルグリセロールリパーゼ阻害剤としてのアゼチジニルジアミド |
| WO2015179559A2 (en) * | 2014-05-21 | 2015-11-26 | Abide Therapeutics, Inc. | Pyrazole compounds and methods of making and using same |
| WO2016014975A2 (en) * | 2014-07-25 | 2016-01-28 | Northeastern University | Urea/carbamates faah magl or dual faah/magl inhibitors and uses thereof |
| WO2017087858A1 (en) * | 2015-11-20 | 2017-05-26 | Abide Therapeutics, Inc. | Pyrazole compounds and methods of making and using same |
| US10519134B2 (en) * | 2015-11-20 | 2019-12-31 | Lundbeck La Jolla Research Center, Inc. | Pyrazole compounds and methods of making and using same |
| KR20170128029A (ko) * | 2016-05-13 | 2017-11-22 | 삼성에스디아이 주식회사 | 태양전지 전극 형성용 조성물 및 이로부터 제조된 전극 |
| EP3571202B1 (en) * | 2017-01-23 | 2021-06-30 | Pfizer Inc. | Heterocyclic spiro compounds as magl inhibitors |
| US10927105B1 (en) * | 2017-05-23 | 2021-02-23 | Lundbeck La Jolla Research Center, Inc. | Pyrazole MAGL inhibitors |
| EA201992409A1 (ru) * | 2017-05-23 | 2020-03-23 | Лундбекк Ла-Хойя Рисерч Сентер, Инк. | Ингибиторы magl на основе пиразола |
-
2019
- 2019-11-26 AU AU2019389017A patent/AU2019389017B2/en not_active Expired - Fee Related
- 2019-11-26 CN CN201980090281.5A patent/CN113347971A/zh active Pending
- 2019-11-26 JP JP2021529827A patent/JP2022509206A/ja active Pending
- 2019-11-26 BR BR112020015043-6A patent/BR112020015043A2/pt unknown
- 2019-11-26 CA CA3120577A patent/CA3120577A1/en active Pending
- 2019-11-26 KR KR1020217019736A patent/KR20210097734A/ko not_active Ceased
- 2019-11-26 US US17/296,489 patent/US20220031676A1/en not_active Abandoned
- 2019-11-26 MX MX2021006312A patent/MX2021006312A/es unknown
- 2019-11-26 WO PCT/US2019/063451 patent/WO2020112905A1/en not_active Ceased
- 2019-11-26 SG SG11202105320YA patent/SG11202105320YA/en unknown
- 2019-11-26 MA MA054313A patent/MA54313A/fr unknown
- 2019-11-26 EP EP19889241.6A patent/EP3886844A4/en not_active Withdrawn
-
2021
- 2021-05-25 CL CL2021001363A patent/CL2021001363A1/es unknown
- 2021-05-27 IL IL283508A patent/IL283508A/en unknown
- 2021-06-09 ZA ZA2021/03975A patent/ZA202103975B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022509206A5 (https=) | ||
| US20260098036A1 (en) | 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer | |
| JP6964096B2 (ja) | ３−オキソ−２，６−ジフェニル−２，３−ジヒドロピリダジン−４−カルボキサミド類 | |
| US11459312B2 (en) | Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides | |
| JP2021534124A5 (https=) | ||
| JP2020521767A5 (https=) | ||
| US11591311B2 (en) | 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides | |
| AU2018255300A1 (en) | Bicyclic compounds and their use in the treatment of cancer | |
| JP2019512505A5 (https=) | ||
| CN118843630A (zh) | 作为pkmyt1抑制剂的杂芳族化合物及其用途 | |
| WO2019101641A1 (en) | 2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor anatgonists | |
| RU2013114771A (ru) | Диамиды азетидинила как ингибиторы моноацилглицерол липазы | |
| RU2015115400A (ru) | Гетероароматические соединения и их применение в качестве допаминовых D1 лигантов | |
| CA3082858A1 (en) | 2-phenylpyrimidine-4-carboxamides as ahr inhibitors | |
| JP2024516033A5 (https=) | ||
| WO2018210729A1 (en) | Aromatic sulfonamide derivatives as antagonists or negative allosteric modulators of p2x4 receptor | |
| EA036318B1 (ru) | 6-аминопиридин-3-илтиазолы в качестве модуляторов rort | |
| JP2015502371A5 (https=) | ||
| RU2019109570A (ru) | 8-(азетидин-1-ил)-[1,2,4]триазоло[1,5-а]пиридинилы, композиции и способы их применения | |
| JP6169699B2 (ja) | 脆弱ｘ症候群、パーキンソン病又は逆流性疾患の治療に有用なジアゼピノン誘導体 | |
| JP2024538602A5 (https=) | ||
| RU2021113744A (ru) | Способы лечения заболевания с использованием ингибиторов magl | |
| RU2015144720A (ru) | Трициклические триазольные соединения | |
| NZ790187B2 (en) | C7, C12, and C16 substituted neuroactive steroids and their methods of use |